NASDAQ:SKYE | Cash Flow Statement | Skye Bioscience, Inc.

Complete source-backed cash-flow history.

Available history
2012-04-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$10.79M
2026-03-31-$12.51M$172,886.00-$8.56M$0.00$10.9M-$71,525.00
2025-12-31-$14.44M$180,009.00-$9.77M$0.00-$2.8M$11,413.00
2025-09-30-$12.75M
2025-06-30-$17.62M
2025-03-31-$11.1M$177,379.00-$9.19M$6,312.00-$12.81M$0.00
2024-12-31-$9.75M$175,293.00-$8.17M$50,024.00$90,410.00$5,618.00
2024-09-30-$3.9M$47,519.00
2024-06-30-$7.9M
2024-03-31-$5.02M$27,560.00-$4.71M$3,181.00$1.14M$85.65M
2023-12-31-$4.42M$86,144.00-$3.84M$7,017.00-$7,017.00-$22,654.00
2023-09-30-$24.95M$12,788.00
2023-06-30-$3.11M
2023-03-31-$5.17M-$4.06M$1,860.00$5.53M-$45,307.00
2022-12-31-$9.89M-$4.87M$12,504.00$5.67M$34,161.00
2022-09-30-$3.13M
2022-06-30-$3.42M
2022-03-31-$3.04M-$2.91M$1,999.00-$1,999.00-$59,263.00
2021-12-31-$2.51M-$1.97M$54,038.00-$54,038.00-$83,722.00
2021-09-30-$1.82M
2021-06-30-$2.02M
2021-03-31-$2.16M-$1.35M$10,696.00-$10,696.00$4.04M
2020-12-31-$1.5M-$1.79M$7,230.00-$7,230.00$38,000.00
2020-09-30-$1.3M
2020-06-30-$1.42M
2020-03-31-$2.34M-$1.27M$0.00$0.00$0.00
2019-12-31$4.85M-$1.5M$2.01M
2019-09-30-$4.93M
2019-06-30$15.91M
2019-03-31-$14.77M-$1.43M$3.99M
2018-12-31-$6.22M-$1.01M$0.00$0.00$1.81M
2018-09-30-$2.1M
2018-06-30-$2.66M
2018-03-31-$8.21M-$1.05M$1,059.00-$1,059.00$3.74M
2017-12-31-$628,184.00-$2.14M$2.38M
2017-09-30-$480,133.00
2017-06-30-$702,764.00
2017-03-31-$1.28M-$816,405.00
2016-12-31-$1.12M-$662,778.00$1.00
2016-09-30-$945,271.00
2016-06-30$573,093.00
2016-03-31-$1.69M-$1.15M$11,116.00
2015-12-31-$691,184.00-$1.11M$0.00
2015-09-30-$1.18M
2015-06-30-$2.06M
2015-03-31-$910,225.00-$751,694.00
2014-12-31-$1.7M-$802,640.00$10,873.00
2014-09-30-$858,518.00
2014-07-31$7,760.00
2014-06-30-$142,920.00
2014-04-30-$13,514.00
2014-03-31-$30,101.00
2014-01-31$3,620.00-$4,145.00
2013-12-31-$30,100.00
2013-10-31-$5,169.00-$8,756.00$0.00
2013-09-30-$30,101.00
2013-07-31-$712.00$3,854.00
2013-04-30$2,069.00$3,854.00
2013-01-31$160.00-$12,489.00$47,471.00
2012-10-31$4,656.00$1,525.00
2012-07-31$55.00
2012-04-30-$381.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$55.92M$723,352.00-$43.06M$6,312.00-$19.5M$29,571.00
2024-12-31-$26.57M$298,640.00-$25.24M$1.6M-$245,615.00$83.56M
2023-12-31-$37.64M$124,251.00-$13.95M$12,550.00$6.6M$16.44M
2022-12-31-$19.48M-$12.74M$28,060.00$5.21M-$208,794.00
2021-12-31-$8.52M-$6.47M$90,866.00-$90,866.00$13.08M
2020-12-31-$6.56M-$6.05M$7,230.00-$7,230.00$6.7M
2019-12-31$1.05M-$6.03M$6M
2018-12-31-$19.19M-$3.94M$4,385.00-$4,385.00$5.54M
2017-12-31-$3.09M-$3.33M$19,654.00-$19,654.00$3.51M
2016-12-31-$3.18M-$3.55M$11,117.00
2015-12-31-$4.84M-$3.73M$1,982.00
2014-12-31-$2.73M-$1.76M$23,262.00
2013-12-31-$120,403.00
2013-10-31-$3,782.00-$14,495.00$49,116.00
2012-10-31$4,509.00$1,928.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.